AbCellera Biologics (ABCL) Change in Account Payables (2020 - 2024)
AbCellera Biologics (ABCL) posted Change in Account Payables of $4.9 million for Q2 2024, up 200.0% on a QoQ basis from -$4.9 million in Q1 2024, and up 146.57% year-over-year from $2.0 million in Q3 2023.
AbCellera Biologics (ABCL) Change in Account Payables (2020 - 2024) Analysis & Trends
AbCellera Biologics' Change in Account Payables history runs 5 years deep, the most recent figure standing at $4.9 million for Q2 2024.
- Quarterly Change in Account Payables rose 146.57% year-over-year to $4.9 million in Q2 2024, while the trailing twelve-month figure through Sep 2024 was $14.4 million (up 4490.55% YoY) and the FY2022 annual result came in at -$3.2 million, down 325.71% from the prior year.
- Change in Account Payables was $4.9 million for Q2 2024 at AbCellera Biologics, up from -$4.9 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $27.9 million in Q4 2021 and bottomed at -$22.9 million in Q3 2021.
- A 5-year average of $175823.5 and a median of $751000.0 in 2022 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 653.11% in 2021, while the deepest fall reached 4473.08% in 2021.
- AbCellera Biologics' Change in Account Payables stood at $3.7 million in 2020, then surged by 653.11% to $27.9 million in 2021, then slumped by 94.55% to $1.5 million in 2022, then soared by 844.95% to $14.4 million in 2023, then slumped by 66.13% to $4.9 million in 2024.
- Business Quant data shows ABCL's Change in Account Payables at $4.9 million in Q2 2024, -$4.9 million in Q1 2024, and $14.4 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4.88 Mn |
| Jun 30, 2024 | 4.88 Mn |
| Mar 31, 2024 | -4.88 Mn |
| Mar 31, 2024 | -4.88 Mn |
| Sep 30, 2023 | 14.40 Mn |
| Sep 30, 2023 | 14.40 Mn |
| Jun 30, 2023 | -10.48 Mn |
| Jun 30, 2023 | -10.48 Mn |
| Mar 31, 2023 | -5.78 Mn |
| Mar 31, 2023 | -5.78 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | -2.80 Mn |
| Sep 30, 2022 | -2.80 Mn |
| Jun 30, 2022 | -2.63 Mn |
| Jun 30, 2022 | -2.63 Mn |
| Mar 31, 2022 | 751,000.00 |
| Mar 31, 2022 | 751,000.00 |
| Dec 31, 2021 | 27.95 Mn |
| Dec 31, 2021 | 27.95 Mn |